The experts at the UPMC Liver Cancer Center often use intrahepatic pump therapy to treat hepatic (liver) metastases from colorectal cancer.
This allows us to administer a much higher concentration of the chemotherapy where you need it most — directly on the liver tumor itself.
People who most benefit from intrahepatic pump therapy include those who have:
To schedule an appointment, or for more information, call the UPMC Liver Cancer Center, toll-free, at 1-855-745-4837.
By administering the chemotherapy directly into the liver, we can use a much higher concentration of the chemotherapy with fewer systemic side effects.
Particularly for colon cancer metastases to the liver, there is evidence for a higher response rate in patients treated with the chemotherapy drug FUDR® (floxuridine) delivered by an implanted hepatic artery pump.
Recent publications have shown that patients who have this form of chemotherapy after surgical resection of tumor metastases from the liver, are much less likely for tumor recurrence than patients who are not treated this way.
A surgeon from the Liver Cancer Center will: